Tempol attenuates renal injury but not hypertension in obese (fa-facp), diabetic, ZSF1 rats

被引：0
|
作者：
Tofovic, SP
Salah, E
Zhang, MS
机构：
[1] Univ Pittsburgh, Sch Med, Dept Med, Ctr Clin Pharmacol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA
来源：
HYPERTENSION | 2003年 / 42卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P85
引用
收藏
页码：421 / 421
页数：1
相关论文
共 50 条
  • [31] Empagliflozin improves diastolic function in obese ZSF1 rats by restoring the cardiac mitochondrial respiratory capacity
    Schauer, A.
    Langner, E.
    Augstein, A.
    Winzer, E.
    Fabig, G.
    Linke, A.
    Adams, V.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [32] Dose-dependent effects of losartan and salt-sensitivity of diabetic nephropathy in ZSF1 rats
    Plato, Craig F.
    Silva, Stacia L.
    Joly, Kristin M.
    Horn, Todd R.
    FASEB JOURNAL, 2013, 27
  • [33] An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model
    Zhou, Xiaoyan
    Zhang, Ji
    Haimbach, Robin
    Zhu, Wei
    Mayer-Ezell, Rosemary
    Garcia-Calvo, Margarita
    Smith, Elizabeth
    Price, Olga
    Kan, Yanqing
    Zycband, Emanuel
    Zhu, Yonghua
    Hoek, Maarten
    Cox, Jason M.
    Ma, Lijun
    Kelley, David E.
    Pinto, Shirly
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2017, 5 (05):
  • [34] DPP-4 inhibition by Linagliptin prevents cardiac inflammation, fibrosis, hypertrophy, and stiffness in obese ZSF1 rats
    Cuijpers, I.
    Carai, P.
    Papageorgiou, A.
    Klein, T.
    Jones, E.
    Hamdani, N.
    Heymans, S.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S31 - S31
  • [35] A Novel Dual Soluble Epoxide Hydrolase Inhibitor/Cyclooxygenase-2 Inhibitor Treats Type 2 Diabetic Complications in Complications in Obese ZSF1 Rats
    Khan, Abdul Hye
    Kolb, Lauren
    Skibba, Melissa
    Yeboah, Michael M.
    Chesnik, Marla A.
    Hwang, Sung H.
    Hammock, Bruce D.
    Imig, John D.
    FASEB JOURNAL, 2019, 33
  • [36] Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats
    Hisaki, R
    Fujita, H
    Saito, F
    Kushiro, T
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 707 - 713
  • [37] Paradoxically reduced pulmonary vascular resistance and abnormal vascular remodeling in the obese spontaneously hypertensive heart failure ZSF1 rats
    Buncha, Vadym
    Bagi, Zsolt
    PHYSIOLOGY, 2023, 38
  • [38] Evaluation of Zucker Diabetic Fatty and ZSF1-Obese Rats as Potential Models for Diabetic Retinopathy.
    Collins, Margaret E.
    Kolodziej, Collin
    Sharp, Randy
    Anderson, Keith
    Wells, Patty
    Mack, Taylor
    Sprague, Christopher
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [39] Metabolic and endocrine effects of interleukin-1 in obese, diabetic Zucker fa/fa rats
    delRey, A
    MongeArditi, G
    Klusman, I
    Besedovsky, HO
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 (04) : 317 - 326
  • [40] A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats
    Signore, Pierre E.
    Guo, Guangjie
    Wei, Zhihua
    Zhang, Weihua
    Lin, Al
    del Balzo, Ughetta
    PLOS ONE, 2021, 16 (08):
12345